Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-122583
Filing Date
2025-12-18
Accepted
2025-12-18 16:50:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6921
  Complete submission text file 0001104659-25-122583.txt   8609
Mailing Address 2750 SAND HILL RD MENLO PARK CA 94025
Business Address 2750 SAND HILL RD MENLO PARK CA 94025 650-233-2750
KPCB PANDEMIC & BIO DEFENSE FUND LLC (Filed by) CIK: 0001356809 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G/A

Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Subject) CIK: 0001400118 (see all company filings)

EIN.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94156 | Film No.: 251583727
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)